Amicus, Shire enter into potential $440 million deal NACDS Foundation supports DEA Musem exhibit on drug diversion Mirixa announces launch of MirixaPro 2.3 MTM program for pharmacists Avandia sales falling as doctors prescribe alternatives Remicade usage hits 1 million mark Watson files application with FDA for generic YAZ Giant Eagle to expand $4 generic prescription program Novo Nordisk, undaunted by Exubera's performance, continues developing AERx New vaccine may make hypertension a thing of the past DrSN's annual Industry Issues Summit to be held Dec. 4 First Previous 2643 2644 2645 2646 2647 Next Last